SMTL ID : 6rn8.1

RIP2 Kinase Catalytic Domain complex with 2(4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)quinazolin7yl)oxy)ethyl phosphate

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.69 Å

Oligo State

homo-dimer

Ligands

2 x K9T: 2-[4-(1,3-benzothiazol-5-ylamino)-6-~{tert}-butylsulfonyl-quinazolin-7-yl]oxyethyl dihydrogen phosphate(Non-covalent)

K9T.1: 19 residues within 4Å: Chain A: L.25, S.26, V.33, A.46, K.48, E.67, L.71, L.80, I.94, T.96, E.97, Y.98, M.99, G.102, S.103, E.106, L.154, A.164, D.165 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.33, A:K.48, A:L.80, A:T.96, A:L.154, A:L.154, A:A.164 Hydrogen bonds: A:Y.98, A:M.99, A:D.165 Water bridges: A:R.110, A:R.110, A:R.110 K9T.3: 20 residues within 4Å: Chain B: L.25, S.26, V.33, A.46, K.48, E.67, L.71, L.80, I.94, T.96, E.97, Y.98, M.99, P.100, G.102, S.103, E.106, L.154, A.164, D.165 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:V.33, B:K.48, B:T.96, B:L.154, B:L.154, B:A.164 Hydrogen bonds: B:K.48, B:T.96, B:Y.98, B:Y.98, B:M.99, B:D.165, B:D.165 Water bridges: B:D.165

1 x CA: CALCIUM ION(Non-covalent)

CA.2: 1 residues within 4Å: Chain B: E.113 5 PLIP interactions: 1 interactions with chain B, 4 Ligand-Water interactions Metal complexes: B:E.113, H2O.7, H2O.7, H2O.7, H2O.11

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Haile, P.A. et al., Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases. J.Med.Chem. (2019)

Release Date

2019-07-17

Peptides

Receptor-interacting serine/threonine-protein kinase 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Receptor-interacting serine/threonine-protein kinase 2

Related Entries With Identical Sequence